Saudi Arabia vs Western Pacific (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc)
Saudi Arabia
98.0%
in 2025
Western Pacific (WHO region)
34.0%
in 2025
Saudi Arabia rank
11th
Western Pacific (WHO region) rank
11th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Saudi Arabia
- Western Pacific (WHO region)
How they compare
Saudi Arabia currently reports 98.0% against 34.0% in Western Pacific (WHO region), a difference of 64.0%.
That makes Saudi Arabia's figure about 2.9 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Western Pacific (WHO region) ahead.
Saudi Arabia ranks 11th and Western Pacific (WHO region) ranks 11th of 194 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.0% | 1.0% | 48.0% | Saudi Arabia |
| 2010s | 97.8% | 7.8% | 90.0% | Saudi Arabia |
| 2020s | 96.8% | 24.8% | 72.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Saudi Arabia or Western Pacific (WHO region)?
- Saudi Arabia, at 98.0% against 34.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Saudi Arabia and Western Pacific (WHO region)?
- 64.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Western Pacific (WHO region)?
- 18 years are reported by both, from 2008 to 2025.
- How do Saudi Arabia and Western Pacific (WHO region) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Saudi Arabia ranks 11th and Western Pacific (WHO region) ranks 11th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.